Pulmonx Corp
Calidad de datos: 100%
LUNG
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
$1.37
▲
$0.08
(5.81%)
Cap. Mercado: 57.65 M
Precio
$1.37
Cap. Mercado
57.65 M
Rango del Día
$1.24 — $1.38
Rango de 52 Semanas
$1.13 — $5.49
Volumen
223,602
Apertura $1.29
Promedio 50D / 200D
$1.53
10.71% below
Promedio 50D / 200D
$1.90
28.15% below
Quick Summary
Puntos Clave
Revenue grew 16.93% annually over 5 years — strong growth
Negative free cash flow of -32.83 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 8.92%
Capital efficient — spends only 0.50% of revenue on capex
Crecimiento
Revenue Growth (5Y)
16.93%
Above sector avg (9.35%)
Revenue (1Y)8.01%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-83.65%
Below sector avg (-51.02%)
ROIC-35.28%
Net Margin-59.67%
Op. Margin-59.30%
Seguridad
Debt / Equity
0.62
Above sector avg (0.33)
Current Ratio4.86
Interest Coverage-17.01
Valoración
PE (TTM)
-1.07
Above sector avg (-1.98)
P/B Ratio0.96
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -1.1 | -2.0 |
| P/B | 1.0 | 5.1 |
| ROE % | -83.7 | -51.0 |
| Net Margin % | -59.7 | -150.2 |
| Rev Growth 5Y % | 16.9 | 9.3 |
| D/E | 0.6 | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8.01% | Revenue Growth (3Y) | 14.79% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 16.93% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 90.50 M | Net Income (TTM) | -54.00 M |
| ROE | -83.65% | ROA | -37.83% |
| Gross Margin | 74.19% | Operating Margin | -59.30% |
| Net Margin | -59.67% | Free Cash Flow (TTM) | -32.83 M |
| ROIC | -35.28% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.62 | Current Ratio | 4.86 |
| Interest Coverage | -17.01 | Asset Turnover | 0.63 |
| Working Capital | 88.36 M | Tangible Book Value | 57.70 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.07 | Forward P/E | N/A |
| P/B Ratio | 0.96 | P/S Ratio | 0.64 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -56.94% | ||
| Market Cap | 57.65 M | Enterprise Value | 18.34 M |
| Per Share | |||
| EPS (Diluted TTM) | -1.33 | Revenue / Share | 2.14 |
| FCF / Share | -0.78 | OCF / Share | -0.77 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0.50% | FCF Conversion | 60.79% |
| SBC-Adj. FCF | -55.66 M | Growth Momentum | -8.92 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 90.50 M | 83.79 M | 68.68 M | 53.66 M | 48.42 M |
| Net Income | -54.00 M | -56.39 M | -60.84 M | -58.92 M | -48.66 M |
| EPS (Diluted) | -1.33 | -1.44 | -1.60 | -1.59 | -1.35 |
| Gross Profit | 67.14 M | 62.00 M | 50.75 M | 39.87 M | 35.63 M |
| Operating Income | -53.66 M | -57.70 M | -61.94 M | -58.64 M | -47.30 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 19.49 M | 17.57 M | 18.08 M | 15.40 M | 13.06 M |
| SG&A Expenses | 101.31 M | 102.14 M | 94.61 M | 83.11 M | 69.87 M |
| D&A | — | — | — | — | — |
| Interest Expense | 3.16 M | 3.51 M | 3.23 M | 1.07 M | 829,000.0 |
| Income Tax | 626,000.0 | 500,000.0 | 571,000.0 | 353,000.0 | 343,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 129.29 M | 162.85 M | 177.78 M | 193.68 M | 235.17 M |
| Total Liabilities | 75.18 M | 77.04 M | 59.47 M | 39.67 M | 41.93 M |
| Shareholders' Equity | 54.12 M | 85.81 M | 118.32 M | 154.01 M | 193.24 M |
| Total Debt | 37.20 M | 40.35 M | 39.40 M | 17.32 M | 17.42 M |
| Cash & Equivalents | 69.75 M | 70.91 M | 83.55 M | 101.74 M | 148.48 M |
| Current Assets | 101.68 M | 136.25 M | 150.42 M | 168.95 M | 208.00 M |
| Current Liabilities | 20.06 M | 24.44 M | 23.16 M | 18.49 M | 17.55 M |
{"event":"ticker_viewed","properties":{"ticker":"LUNG","listing_kind":"stock","pathname":"/stocks/lung","exchange":"Nasdaq","country":"US"}}


